PARP1 and head and neck squamous cell carcinoma: Therefore, we examined the impact of the strong PARP trapper talazoparib in enhancing the radiosensitivity of HNSCC cells grown as 3D spheroids, focussing on the HPV-negative HNSCC spheroids due to their inherent radioresistance.